Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01327287 · ClinicalTrials.gov registry record
Early Aggressive Pain Management is Associated With Improved Outcomes in Blunt Thoracic Trauma
A clinical trial, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- 43
- Enrollment target
NCT01327287: Clinical Trial study, sponsored by University of California, San Francisco.
NCT01327287 is a clinical trial that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01327287 was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- 43 participants
- Enrollment target
Study Summary
This study is designed to analyze the use of early aggressive pain management with thoracic epidural in eligible patients with blunt thoracic trauma.
Primary Outcome
the hospital length of stay will be assessed for patients who received thoracic epidural compared to those who did not receive thoracic epidural.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2010-02 |
| Est. Completion | 2013-02 |
Why NCT01327287 stopped before completion
NCT01327287 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01327287 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01327287 about?
NCT01327287 is a clinical study titled "Early Aggressive Pain Management is Associated With Improved Outcomes in Blunt Thoracic Trauma". This study is designed to analyze the use of early aggressive pain management with thoracic epidural in eligible patients with blunt thoracic trauma.
What is the current status of trial NCT01327287?
This trial is currently terminated. The enrollment target is 43 participants. The study started on 2010-02. Estimated completion is 2013-02.
Who is sponsoring clinical trial NCT01327287?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia